Fidelity Investments’s SAB Biotherapeutics SABS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-34	Closed	-$236	–	5668
2023 Q4	$236	Hold	34	–	–	﹤0.01%	4868
2023 Q3	$216	Buy	+34	New	+$216	﹤0.01%	4782
2022 Q4	–	Sell	-900	Closed	-$6K	–	5560
2022 Q3	$6K	Buy	+900	New	+$6K	﹤0.01%	4265